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Abstract Arginine-specific ADP-ribosyltransferase present in 
granules of chicken polymorphonuclear leukocytes (so-called 
heterophils) is released into the extracellular space by stimulus of 
calcium ionophore A23187 or opsonized zymosan [Terashima et 
al. (1996) J. Biochem. 120, 1209-1215]. In the present work, we 
examined extracellular targets of the released transferase and 
identified tuftsin, a phagocytosis-stimulating tetrapeptide derived 
from leukokinin, as a preferential substrate of the enzyme in 
chicken plasma. Specific binding of FITC-tuftsin to murine 
peritoneal macrophages, observed under a fluorescent micro-
scope, was impaired by ADP-ribosylation of the labelled peptide. 
Phagocytic assay analyzed by flow cytometry revealed that 
ADP-ribosylation of tuftsin decreased its phagocytosis-stimulat-
ing activity towards the macrophages. Thus, the ADP-ribosyla-
tion of tuftsin apparently decreases its biological activity and 
ADP-ribosylation may possibly be involved in inflammatory 
processes through alterations in tuftsin activity. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Arginine-specific mono ADP-ribosylation is a post-transla-
tional modification, in which the ADP-ribose moiety of NAD 
is transferred to the guanidine group of the arginine residue of 
various peptides and proteins. Cholera toxin, a well-known 
example of arginine-specific ADP-ribosyltransferase, ADP-ri-
bosylates an arginine residue of G sa to inhibit its GTPase 
activity [1,2]. Activity of the ADP-ribosyltransferase had 
been also detected in animal tissues or cells including avian 
blood cells [3-5] and mammalian skeletal muscle [6,7]. Since 
cells contain ADP-ribose donor NAD inside, the transferase 
has been thought to regulate functions of intracellular pro-
teins such as Gsoc or actin [8,9] via the modification of argi-
nine residues of these proteins. 
Recent studies have revealed that some arginine-specific 
ADP-ribosyltransferases are expressed on the surface of mur-
ine T lymphocytes [10] or myoblasts [11], as GPI-anchored 
proteins, and can modify cell surface proteins including integ-
rins [11-13]. This suggests an extracellular ADP-ribosylation 
and involvement of the modification in control of cell adhe-
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sion. We identified an arginine-specific ADP-ribosyltransfer-
ase in cytoplasmic granules of chicken heterophils [4]. From 
primary structure of the transferase and expression experi-
ments of its cDNA in eukaryotic cells, the transferase seemed 
to be a secretable protein [5]. We demonstrated that chicken 
ADP-ribosyltransferase is released from the granules by the 
stimulus of calcium ionophore A23187 with calcium or serum-
opsonized zymosan [14]. 
We attempted to search for extracellular substrates for the 
released transferase in the fresh chicken plasma, and found 
that the tetrapeptide tuftsin (Thr-Lys-Pro-Arg) is a preferen-
tial substrate for the transferase. Tuftsin is a naturally occur-
ring tetrapeptide produced by leukokininase at residues 289-
292 of the CH2 domain in the leukokinin, a fraction of im-
munoglobulin [15,16]. Tuftsin binds specific cell surface recep-
tors of polymorphonuclear neutrophils and macrophages and 
stimulates the functions of these cells, including phagocytosis, 
mobility and chemotaxis [17], thereby exerting anti-microbial 
and anti-tumor activities to play a crucial role in host defense 
mechanisms [18,19]. 
We show here that arginine-specific ADP-ribosyltransferase 
released from the heterophils modifies tuftsin in situ and that 
this modification suppressed its phagocytosis-stimulating ac-
tivity towards murine peritoneal macrophages, presumably by 
inhibiting the binding of tuftsin to the cell surface receptors. 
2. Materials and methods 
2.1. Materials 
Chickens were obtained from a local slaughterhouse, and BALB/c 
mice were from Charles River Co. [adenylate-32P]NAD (29.6 TBq/ 
mmol) was purchased from New England Nuclear. Tuftsin, EDTA 
and PMSF were from Sigma Co. Ltd. Fluorescent latex beads (CAT 
#09719, 1.5 um diameter) was from Polyscience, Inc. and FITC was 
from Wako Chemical Co. Ltd. 
2.2. Analysis of ADP-ribosylated peptide in chicken plasma 
Fresh chicken plasma (100 ul) collected with 1 mM EDTA and 0.2 
mM PMSF was incubated with 50 mM Tris-HCl (pH 9.0), 5 mM 
dithiothreitol, 50 uM [adenylate-32P]NAD (55 kBq/tube) and 100 ng 
purified chicken heterophil ADP-ribosyltransferase [4] for 1 h at 25°C 
in a total volume of 200 ul. After the incubation, the mixture was 
added by 10% PCA (v/v) and centrifuged at 15 000 Xg for 10 min. The 
obtained supernatant was applied to a reverse-phase HPLC column 
(Cig, Nakalai AR) and developed with a linear gradient of 0-60% 
CH3CN in 0.1% TFA for 60 min at a flow rate of 0.3 ml/min. The 
effluent was monitored by absorbance at 214 nm, and collected every 
0.3 ml. The radioactivity of each fraction was measured. One highly 
radioactive fraction eluted after NAD was collected and was further 
purified with re-chromatography, under the same conditions described 
above. Amino-acid sequence analysis of the radioactive material was 
done by automated Edaman degradation, using a model-477 gas-
phase peptide sequencer and a model 120 PTH amino-acid analyzer 
(Applied Biosystems). 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)00784-9 
228 M. Terashima et al.lFEBS Letters 412 (1997) 227-232 
£ 
o 
c 
TO 
JD o </) 
< 
<L> 
3 
E 
a. 
o 
u 
as g 
T3 
ro 
X 
0.5 - 100 
0 
30 
^ 10 
c 
o 
*-• 
< 
Retention time (min) 
Fig. 1. Separation of [32P]ADP-ribosylated peptide in chicken plasma. Fresh chicken plasma (100 ul) incubated with the heterophil ADP-ribo-
syltransferase in the presence of [32P]NAD was fractionated with reverse-phase HPLC, as described in Section 2. The elution profile was moni-
tored by the absorbance at 214 nm (A) and the radioactivity (B). An arrowhead in panel A indicates the fraction containing the radiolabelled 
peptide. 
2.3. ADP-ribosylation of tuftsin 
Tuftsin (100 nmol) was incubated with 50 mM Tris-HCl (pH 9.0), 
5 mM dithiothreitol, 1 mM NAD and 50 ng purified chicken arginine-
specific ADP-ribosyltransferase in a total volume of 500 ill for 2 h at 
25°C. After the incubation, the reaction mixture was applied to a 
reverse-phase HPLC column (Ci8, Nakalai MS) and eluted with a 
linear gradient of 0-10% CH3CN in 0.1% TFA for 30 min at a 
flow rate of 0.3 ml/min. The elution profile was monitored by absorb-
ance at 254 nm. The fraction containing ADP-ribosylated tuftsin, 
eluted at 27.6 min was collected and lyophilized. 
2.4. Preparation of peritoneal macrophages 
Macrophages obtained from peritoneal exdates of mice that had 
been given 4 ml of 3.5% solution of thioglycollate broth intraperito-
neally 5 days before killing [20], were washed twice with Hanks' bal-
anced saline solution (HBSS) and plated at the concentration of 
5X 105 cells per 35 mm culture dishes with medium RPMI 1640 con-
taining 10% fetal calf serum (FCS), 100 ug/ml streptomycin and 100 
unit/ml penicillin G. After incubation for 2 h at 37°C in a C0 2 in-
cubator, the cells were washed twice with phosphate-buffered saline 
(PBS), and cultured in medium RPMI 1640 containing 10% FCS. 
2.5. Binding of FITC-tuftsin and FITC-tuftsin-ADP-ribose to murine 
peritoneal macrophages 
Fluorescent labelling and subsequent purification of tuftsin were 
done according to Amoscato et al. [21] but with some modifications. 
Briefly, FITC (1 mg) was reacted with 500 ug tuftsin in 0.1 M 
NaHC03/Na2C03 (pH 8.3) for 4 h at room temperature in a total 
volume of 300 ul. The reaction mixture was sequentially applied to the 
cation-exchanger (Radial-PAK™ 8P SCX, Waters) and reverse-phase 
column (Cis Nakalai AR) connected to the HPLC system (Waters, 
model 510, scanning fluorescence detector 474, multiwavelength M-
490). The amino-acid composition and concentration of purified 
FITC-tuftsin were determined using amino-acid analyzer (Hitachi 
835) monitored at 570 nm and 440 nm using ninhydrin as a detecting 
reagent, and intact tuftsin as a control. The ratio of amino-acids 
analyses of FITC-tuftsin was 0.16:0.95:1.0:1.0 from the N-terminus, 
much the same ratio as described previously [21]. The obtained FITC-
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tuftsin was ADP-ribosylated and further purified with the reverse-
phase HPLC as described in Section 2.3. 
The binding of FITC-tuftsin and ADP-ribosylated FITC-tuftsin 
towards murine peritoneal macrophages was observed under a fluo-
rescent microscope (Nikon, Japan). 
2.6. Phagocytosis assay and flow cytometry 
Fluorescent latex beads were incubated with 1% bovine serum al-
bumin for 30 min at 37°C followed by ultrasonication. The macro-
phages were washed twice with HEPES balanced bath solution (10 
mM HEPES, pH 7.5, 140 mM NaCl, 5 mM KC1, 2 mM CaCl2 and 1 
mM M g C y and preincubated for 30 min at room temperature. After 
adding the fluorescein-labelled latex beads (2X 107/dish) and indicated 
concentrations of tuftsin, the cells were further incubated for 15 min 
at room temperature, washed five times with PBS and then incubated 
with PBS containing 0.2% trypsin (Difco) and 0.5 mM EDTA for 15 
min at 37°C. Each macrophage preparation was fixed with 0.5% glu-
taraldehyde, collected with pipetting and scraping and centrifuged at 
400 Xg for 5 min. The precipitated cells were applied to flow cyto-
metric analyses using a FACStar (Becton Dickson Immunocytometry 
Systems) [22-24]. Analyses were made on 104 cells per tube. The 
percentage of phagocytosis (PP) was defined as the percentage of 
macrophages that ingested one or more particles. The phagocytic in-
dex (PI) was defined as the average number of particles ingested per 
macrophage and calculated by dividing the total number of ingested 
beads by the total number of macrophages. Under these conditions, 
the estimated Km value of tuftsin for phagocytosis was 0.1 (J.M, as 
described by Najjar [15] and maximal phagocytosis-stimulating activ-
ity of tuftsin occurred at 10 uM concentration and 15 min incubation, 
as described by Nishioka et al. [25,26]. 
A.FITC-TKPR 
B. FITC-TKPR-ADPR 
3. Results and discussion 
To detect extracellular substrates for the arginine-specific 
ADP-ribosyltransferase released from chicken heterophils, 
we incubated chicken plasma with purified heterophil trans-
ferase in the presence of [32P]NAD, and analyzed PCA-soluble 
material of the plasma on reversed-phase HPLC (Fig. 1). Ra-
dioactive peaks I and II were degradative products of 
[32P]NAD and [32P]NAD itself, respectively. Peak III seemed 
to be [32P]ADP-ribosylated peptide. When heterophils (5 X 106 
cells) suspended in plasma were incubated with 5 uM calcium 
ionophore A23187 with 1 mM calcium and 50 u.M [32P] NAD 
[14], much the same results were obtained (data not shown). 
When a fraction of peak III was subjected to amino-acid 
sequence analysis, the sequence of the peptide in the fraction 
was revealed to be Thr-Lys-Pro-Arg, known as tuftsin (Table 
1). The same four amino acids were obtained with a low yield 
of arginine by amino-acid composition analysis of the labelled 
peptide (data not shown). When synthetic tuftsin was ADP-
ribosylated with the heterophil transferase and [32P]NAD, the 
modified peptide was eluted at the same retention time at that 
of peak III in Fig. 1, on the reverse-phase HPLC, and anal-
yses of the peptide sequence or amino-acid composition also 
demonstrated a low yield of arginine (data not shown). These 
Table 1 
Amino-acid sequencing of the radiolabelled peptide 
Cycle Amino acid 
Thr 
Lys 
Pro 
Arg 
N.D. 
Yield (pmol) 
44.5 
25.8 
29.8 
3.1 
-
Sequence analysis of the radiolabelled peptide obtained from the frac-
tion indicated by arrowhead in Fig. 1, was made as described in 
Section 2. 
Fig. 2. Binding of FITC-TKPR (A) and FITC-TKPR-ADP-ribose 
(B) to murine peritoneal macrophages. Murine peritoneal macro-
phages monolayered on a slide glass were incubated with each 
FITC-conjugate for 5 min at room temperature. After a wash in 
PBS, photographs of the cells were taken using a fluorescent micro-
scope. FITC-TKPR and FITC-TKPR-ADP-ribose mean FITC-la-
belled tuftsin and ADP-ribosylated FITC-labelled tuftsin, respec-
tively. 
results indicate that peak III is ADP-ribosylated tuftsin, and 
that the tetrapeptide is preferentially ADP-ribosylated by ex-
tracellularly released ADP-ribosyltransferase with NAD in 
plasma. The low yield of arginine may be due to the disrupted 
determination caused by the covalent modification of ADP-
ribose, as described previously [9]. ADP-ribosylation of syn-
thesized tuftsin with purified heterophil transferase exhibited 
one mol ADP-ribose incorporation into one mol tuftsin (data 
not shown). When the heterophils (5 X 107/ml) were stimulated 
with 5 ixM A23187 and 1 mM CaCl2 in the presence of 1 uM 
tuftsin (estimated concentration in chicken plasma) and 10 
uM [adenylate-32P]NAD at 37°C for 5 min, about 50% of 
added tuftsin was ADP-ribosylated (data not shown). 
Tuftsin, a plasma peptide derived from leukokinin, stimu-
lates the function of neutrophils or macrophages, such as 
phagocytosis, mobility or chemotaxis [17]. To examine how 
ADP-ribosylation affects the function of tuftsin, we investi-
gated the effect of ADP-ribosylation on the receptor-binding 
of the peptide, using FITC-labelled tuftsin. FITC-tuftsin 
bound well to the cell-surface receptor of murine peritoneal 
macrophages, whereas ADP-ribosylated FITC-tuftsin scarcely 
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Fig. 3. Flow cytometric profiles for the effect of ADP-ribosylation on tuftsin-induced phagocytosis. Phagocytosis assay and flow cytometric 
analysis were performed as described in Section 2 with 0 (a), 0.1 (b), 1.0 (c) or 10 (d) |iM of tuftsin (solid line), or ADP-ribosylated tuftsin 
(broken line). The data are representative of four separate experiments. 
did so (Fig. 2). Similar results were obtained when binding 
assays were carried out at 4°C for 20 min (data not shown). 
Excess amounts of free tuftsin added simultaneously to the 
FITC-tuftsin eliminated the cell-associated fluorescence, there-
by indicating FITC-tuftsin specifically binds to its own cell 
surface receptor [21,27]. These results are interpreted to 
mean that ADP-ribosylation of tuftsin on the carboxyl-termi-
nal arginine suppresses its binding to the specific receptor on 
macrophages. 
Next, we investigated the stimulation of phagocytosis by 
intact or ADP-ribosylated tuftsin. Murine peritoneal macro-
phages were incubated with 0.1-10 |J,M tuftsin or ADP-ribo-
sylated tuftsin in the presence of fluorescent latex beads, and 
the cell-engulfed fluorescent particles were analyzed by the 
flow cytometry (Fig. 3). Smoothed histograms revealed the 
distribution of non-ingested, one-bead-ingested, two-beads-in-
gested, and more-beads-ingested cell populations. Tuftsin-in-
duced phagocytosis increased with increasing concentrations 
of the peptide while ADP-ribosylated tuftsin caused no re-
markable stimulation of phagocytosis, even at 10 \iM. These 
differences were clearly expressed in the % of phagocytosis 
(PP) and phagocytic index (PI) as shown in Fig. 4. Tuftsin 
enhanced PP and PI, in a dose-dependent manner at the max-
imum of 67.4% and 1.82, respectively, although no increase in 
PP and PI was observed in the case of ADP-ribosylated tuft-
sin. These results indicate that ADP-ribosylation of tuftsin on 
the arginine residue impairs its stimulatory effect on phagocy-
tosis of macrophages. 
ADP-ribosylation of tuftsin on the arginine residue de-
creased its stimulatory activity on phagocytosis of macro-
phages as well as binding of the peptide to the receptor on 
the cells, findings consistent with the documented importance 
of the positive charge on the arginine side chain for its bio-
logical activity [21,28]. In physiologically active peptides con-
taining tuftsin-related domain, such as neurotensin or sub-
stance P, an arginine residue in the domain is probably 
crucial to exert biological effects [29,30]. These peptides may 
possibly serve as targets of the transferase. In this work, we 
examined possible physiological targets of arginine-specific 
ADP-ribosyltransferase secreted to extracellular space from 
cytoplasmic granules of chicken heterophils, in case of stim-
ulation of the cells with calcium ionophore or opsonized zy-
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Fig. 4. Effect of ADP-ribosylation of tuftsin on percentage of phagocytosis (PP) and phagocytic index (PI). PP (A) and PI (B) were calculated 
from the flow cytometric analysis of Fig. 2 as described in Section 2. Open and dotted columns show the effect of tuftsin and ADP-ribosylated 
tuftsin, respectively. 
mosan. We found that tuftsin, a tetrapeptide stimulator of 
neutrophils or macrophages, was specifically ADP-ribosylated 
in situ, and that ADP-ribosylation of tuftsin by the transfer-
ase inhibited stimulatory effects of the peptide on phagocyto-
sis of murine peritoneal macrophages, probably via suppress-
ing specific receptor-binding activity of the peptide. In light of 
these findings, together with the presence of ADP-ribosyl-
transferase in mammal ian neutrophils [31,32], in the site of 
inflammation, ADP-ribosyltransferase released from granulo-
cytes might inhibit phagocytosis-stimulating activity of tuftsin, 
through modification of the arginine residue with an N A D 
supply. Thus, the released transferase would modulate the 
inflammatory process by terminating the signal of tuftsin to 
stimulate phagocytosis in vivo. N A D may be released during 
the exocytosis of the leukocyte granules since nucleotide A T P 
is reported to be secreted into the extracellular space by some 
stimuli [33], or it may be derived from damaged or dead cells. 
We are now examinating whether these possible mechanisms 
can provide the extracellular N A D . 
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